Gore J M
Division of Cardiovascular Medicine, University of Massachusetts Medical School.
Z Kardiol. 1993;82 Suppl 2:143-6.
The proportion of patients with acute myocardial infarction who are currently being treated with thrombolytic therapy is small. It is not readily apparent why the use of thrombolytic therapy is not more widespread. Several factors have been raised to explain the limited use of thrombolytic therapy, including patient age and late presentation after symptom onset. Recent data suggests that the benefits of thrombolytic therapy should be extended to these selected high-risk subgroups. A philosophy of finding a reason not to treat with thrombolytic therapy should be adopted by all practicing clinical cardiologists.
目前正在接受溶栓治疗的急性心肌梗死患者比例较小。溶栓治疗的使用为何没有更广泛普及，原因并不明显。已经提出了几个因素来解释溶栓治疗使用受限的情况，包括患者年龄和症状出现后的延迟就诊。最近的数据表明，溶栓治疗的益处应扩展到这些选定的高危亚组。所有执业临床心脏病专家都应秉持一种理念，即寻找不进行溶栓治疗的理由。
